Innovation in single-cell sequencing unlocks 10x more data from each cell A new single-cell sequencing method yields at least 10 times more data for each individual cell compared to previous techniques. The method, published in Nature Biotechnology on July 5, may help cancer researchers uncover new insights into the biological underpinnings of cancer such as drug resistance.Read More
Oncolytic viruses move closer to becoming effective cancer therapies Scientists are identifying key factors that aid in the effectiveness of oncolytic viruses during the treatment of cancers, which could lead to better immunotherapies and inform clinicians which patients might benefit from the treatment. Findings from a June 22 Nature Communications article point to the clinical relevance and underlying mechanisms of a novel anticancer treatment.Read More
Bruker launches new tools to improve 4D-metabolomics, lipidomics workflows Bruker has launched several products to enhance the accuracy of 4D-metabolomics and lipidomics workflows, including a new ion source for its trapped ion mobility spectrometry time-of-flight (timsTOF) Pro 2 platform and new bioinformatics software for small-molecule workflows.Read More
MolDiscovery algorithm helps scientists find promising small molecules A computer algorithm called molDiscovery uses mass spectrometry data from small molecules to predict the identity of unknown substances, potentially saving researchers time and money in the search for new naturally occurring products with medical uses. The new approach was reported in Nature Communications on June 17.Read More
How spatial biology can impact clinical translational research Building on the success of single-cell technologies, 10X Genomics' Michael Schnall-Levin, PhD, discusses with ScienceBoard.net how the company entered the spatial biology field and how it continues to support the advancement of various clinical translational research efforts.Read More